Software as a Medical Device

Working Group Chair(s)
Marc Lamoureux
Health Canada
Canada
Ambreen Athar
Food and Drug Administration (US FDA)
United States of America
Membership
Regulator and Stakeholder Membership
Status
Current

Software for medical purposes continues to be increasingly important and influential in advancing public health. The Software as a Medical Device (SaMD) Working Group (WG) published the last of 4 technical documents it authored in 2017. Since 2017, regulations related to medical purpose software have evolved and the pace and number of technological advancements continue to increase. 

The goal of the SaMD WG is to review and refine, as needed, the previously published documents to ensure ongoing consistency, predictability, transparency, and quality of premarket regulatory programs and criteria for assessing premarket technical documentation for SaMD. The review will also pay attention to post-market activities, recognizing the speed with which digital health technology develops and the value of taking a total product life cycle approach aligned with the principles of IMDRF.

Participants

Bioing. José Médico Orellano
National Administration of Drugs, Food and Medical Devices (ANMAT)
Carolina Magnatti
National Administration of Drugs, Food and Medical Devices (ANMAT)
Sebastián Ocampo
National Administration of Drugs, Food and Medical Devices (ANMAT)

Dr David Hau
Therapeutic Goods Administration (TGA)
Gabrielle Harradine
Therapeutic Goods Administration (TGA)

Mr Francisco Iran Cartaxo Barbosa
Brazilian Health Regulatory Agency (ANVISA)
Mr Jangley Bahia Costa
Brazilian Health Regulatory Agency (ANVISA)

Janet Hendry
Health Canada
Martina Buljan
Health Canada

Matthias Neumann
German Federal Ministry of Health
Nada Alkhayat
European Commission
Rolf Oberlin Hansen
Danish Medicines Agency
Valerie Soumet
National Agency for the Safety of Medicines and Health Products (ANSM)

Camille Vidal
GE Healthcare
Hyun-Bae Park
Kakao Healthcare
Koen Cobbaert
Philips Healthcare
Tomohisa Fukunaga
Canon Medical Systems

Cassie Scherer
Industry Representatives (GMTA)
Diane Johnson
Johnson & Johnson Medical
Kees Maquelin
Industry Representatives (GMTA)
Mr Toshiaki Nakazato
Canon Medical Systems

Dr Kentaro Kato
Pharmaceuticals and Medical Devices Agency (PMDA)
Dr Madoka Murakami
Ministry of Health, Labour and Welfare (MHLW)
Mr Kuniki Imagawa
Pharmaceuticals and Medical Devices Agency (PMDA)
Yuhei Fukuta
Ministry of Health, Labour and Welfare (MHLW)

Mr Ong Ming Hao
Health Sciences Authority (HSA)
Ms Siew Jie Yee
Health Sciences Authority (HSA)

Byung-Gwan Kim
Ministry of Food and Drug Safety (MFDS)
Rosa Da-yeong Ryoo (Ms)
Ministry of Food and Drug Safety (MFDS)

Elly Gysels
Swissmedic
Rudolf Waelti
Swissmedic

David Grainger
Medicines and Healthcare products Regulatory Agency (MHRA)
Russell Pearson
Medicines and Healthcare products Regulatory Agency (MHRA)

Catherine Bahr
Food and Drug Administration (US FDA)
Wil Vargas
Food and Drug Administration (US FDA)